Shares in Harvard Bioscience climbed 19 percent for the five-day trading period ended Tuesday, leading all gainers in the BCW Index. The company is in the midst of seeking a buyer for its capital equipment business. The only other firm to eclipse 5 percent growth for the tracking period was Invitrogen, whose shares rose 5.3 percent. Stratagene led decliners with a 2.8 percent drop.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.